Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-06 Sale |
2025-02-06 3:58 pm |
Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead |
95,212 | $0 | $0 | 0 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:31 pm |
Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead |
3,908 | $4.17 | $16,296 | 104,945 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Option Award |
2025-04-02 8:15 pm |
2026-04-01 2035-04-01 |
KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:58 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead |
9,733 | $3.65 | 0 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 3:15 pm |
2025-07-01 2034-07-01 |
KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director |
1,778 | $0 | 1,778 (Direct) |
View |
Ownership |
2024-02-29 4:32 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead |
0 | $0 | 278,522 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-03 4:44 pm |
N/A 2033-09-29 |
KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director |
0 | $0 | 5,000 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 8:13 pm |
N/A 2033-03-03 |
KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 8:40 pm |
N/A N/A |
AERIE PHARMACEUTICALS INC | AERI | Hollander David Chief R&D Officer |
927 | $7.05 | 30,749 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:02 pm |
N/A 2032-02-01 |
KIORA PHARMACEUTICALS INC | KPRX | Hollander David Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-11-11 Tax Withholding |
2021-11-15 4:44 pm |
N/A N/A |
AERIE PHARMACEUTICALS INC | AERI | Hollander David Chief R&D Officer |
2,162 | $12.06 | 31,676 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 6:07 pm |
N/A 2031-02-04 |
AERIE PHARMACEUTICALS INC | AERI | Hollander David Chief R&D Officer |
61,000 | $0 | 83,838 (Direct) |
View |
| 2020-11-11 Tax Withholding |
2020-11-12 5:05 pm |
N/A N/A |
AERIE PHARMACEUTICALS INC | AERI | Hollander David Chief R&D Officer |
2,162 | $13.05 | 22,838 (Direct) |
View |